PL2016064T3 - Sposoby wytwarzania związków zawierających pirazol - Google Patents

Sposoby wytwarzania związków zawierających pirazol

Info

Publication number
PL2016064T3
PL2016064T3 PL07761874T PL07761874T PL2016064T3 PL 2016064 T3 PL2016064 T3 PL 2016064T3 PL 07761874 T PL07761874 T PL 07761874T PL 07761874 T PL07761874 T PL 07761874T PL 2016064 T3 PL2016064 T3 PL 2016064T3
Authority
PL
Poland
Prior art keywords
preparation
pyrazole
methods
containing compounds
disorders
Prior art date
Application number
PL07761874T
Other languages
English (en)
Inventor
Xiaohu Deng
Jimmy T Liang
Neelakandha Mani
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PL2016064T3 publication Critical patent/PL2016064T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/16Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL07761874T 2006-05-05 2007-05-04 Sposoby wytwarzania związków zawierających pirazol PL2016064T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74649706P 2006-05-05 2006-05-05
EP07761874A EP2016064B1 (en) 2006-05-05 2007-05-04 Methods for the preparation of pyrazole-containing compounds
PCT/US2007/068210 WO2007131153A2 (en) 2006-05-05 2007-05-04 Methods for the preparation of pyrazole-containing compounds

Publications (1)

Publication Number Publication Date
PL2016064T3 true PL2016064T3 (pl) 2010-08-31

Family

ID=38566748

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07761874T PL2016064T3 (pl) 2006-05-05 2007-05-04 Sposoby wytwarzania związków zawierających pirazol

Country Status (12)

Country Link
US (1) US7915404B2 (pl)
EP (1) EP2016064B1 (pl)
CN (1) CN101479252B (pl)
AT (1) ATE459614T1 (pl)
CY (1) CY1110087T1 (pl)
DE (1) DE602007005117D1 (pl)
DK (1) DK2016064T3 (pl)
ES (1) ES2340217T3 (pl)
PL (1) PL2016064T3 (pl)
PT (1) PT2016064E (pl)
SI (1) SI2016064T1 (pl)
WO (1) WO2007131153A2 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06003150A (es) * 2003-09-17 2006-08-31 Johnson & Johnson Compuestos heterociclicos fusionados.
US7598255B2 (en) * 2005-08-04 2009-10-06 Janssen Pharmaceutica Nv Pyrimidine compounds as serotonin receptor modulators
WO2009058810A1 (en) * 2007-11-02 2009-05-07 Janssen Pharmaceutica N.V. Process for the preparation of substituted 2,4,5,6,7,8-hexahydro-1,2,6-triaza-azulene derivatives
WO2010060854A1 (en) * 2008-11-25 2010-06-03 Nerviano Medical Sciences S.R.L. Bicyclic pyrazole and isoxazole derivatives as antitumor and antineurodegenerative agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0272866A1 (en) * 1986-12-23 1988-06-29 Merck & Co. Inc. 1,4-Benzodiazepines with 5-membered heterocyclic rings
MXPA06003150A (es) 2003-09-17 2006-08-31 Johnson & Johnson Compuestos heterociclicos fusionados.
US7598255B2 (en) 2005-08-04 2009-10-06 Janssen Pharmaceutica Nv Pyrimidine compounds as serotonin receptor modulators

Also Published As

Publication number Publication date
CY1110087T1 (el) 2015-01-14
PT2016064E (pt) 2010-04-16
SI2016064T1 (sl) 2010-07-30
WO2007131153A2 (en) 2007-11-15
ATE459614T1 (de) 2010-03-15
WO2007131153A3 (en) 2008-01-10
EP2016064A2 (en) 2009-01-21
CN101479252B (zh) 2014-01-29
CN101479252A (zh) 2009-07-08
DE602007005117D1 (de) 2010-04-15
US7915404B2 (en) 2011-03-29
ES2340217T3 (es) 2010-05-31
US20070260057A1 (en) 2007-11-08
DK2016064T3 (da) 2010-06-07
EP2016064B1 (en) 2010-03-03

Similar Documents

Publication Publication Date Title
MX2009005252A (es) Aminopirrolidinas como antagonistas del receptor de quimiocina.
MX2010010407A (es) Derivados de 4-aminociclohexanos sustituidos.
MX2009010984A (es) Moduladores de heterociclo cinasa de anillo fusionado.
TW200801013A (en) Substituted benzofused derivatives and their use as vanilloid receptor ligands
MY151246A (en) Benzofuranyl derivatives
UA102251C2 (ru) Производные аминодигидротиазина как ингибиторы васе для лечения болезни альцгеймера
IL183160A0 (en) Indazole-carboxamide compounds
IL193479A0 (en) Modulators of muscarinic receptors
MX2011009369A (es) 2-mercaptoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
WO2007106236A3 (en) Pyrrolo-pyridine kinase modulators
WO2008124849A3 (en) Pyrrolo-pyridine kinase modulators
IN2012DN02493A (pl)
PH12012502236A1 (en) Process for the preparation of piperazinyl and diazepanyl benzamide derivatives
MX2010002899A (es) Derivados de azaciclilisoquinolinona e isoindolinona como antagonistas de la histamina-3.
MX2011008825A (es) 3-aminoisoxazolopiridinas sustituidas como moduladores de kcnq2/3.
WO2008059339A3 (en) Isoquinoline derivatives as vanilloid receptor modulators
MX2011008662A (es) 2-mercapto-3-aminopiridinas sustituidas como moduladores de kcnq2/3.
MX2011009338A (es) 3-amino-2-mercaptoquinolinas sustituidas como moduladores de kcnq2/3.
WO2008152094A3 (en) Substituted acetamides as modulators of the ep2 receptor
PL2016064T3 (pl) Sposoby wytwarzania związków zawierających pirazol
MXPA05012081A (es) Derivados de pirimidina sustituidos.
GB0513886D0 (en) Novel compounds
PH12012500640A1 (en) Fluoro-substituted 3,5 - dicyano -4- (1h-indazol -5- yl) -2,6- dimethyl -1,4- dihydropyridine derivatives and methods of use thereof
MY174411A (en) Novel processes for the preparation of cyclopropyl-amide derivatives
WO2010107897A3 (en) Process for the preparation of histamine h3 receptor modulators